445 related articles for article (PubMed ID: 22336489)
1. Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients.
Voss PJ; Joshi Oshero J; Kovalova-Müller A; Veigel Merino EA; Sauerbier S; Al-Jamali J; Lemound J; Metzger MC; Schmelzeisen R
J Craniomaxillofac Surg; 2012 Dec; 40(8):719-25. PubMed ID: 22336489
[TBL] [Abstract][Full Text] [Related]
2. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
Lopes RN; Rabelo GD; Rocha AC; Carvalho PA; Alves FA
J Oral Maxillofac Surg; 2015 Jul; 73(7):1288-95. PubMed ID: 25871903
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.
Lazarovici TS; Yahalom R; Taicher S; Elad S; Hardan I; Yarom N
J Oral Maxillofac Surg; 2009 Apr; 67(4):850-5. PubMed ID: 19304045
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of bisphosphonate induced osteonecrosis of the jaws.
Williamson RA
Int J Oral Maxillofac Surg; 2010 Mar; 39(3):251-5. PubMed ID: 20015614
[TBL] [Abstract][Full Text] [Related]
5. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
[TBL] [Abstract][Full Text] [Related]
7. What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics.
Freiberger JJ; Padilla-Burgos R; McGraw T; Suliman HB; Kraft KH; Stolp BW; Moon RE; Piantadosi CA
J Oral Maxillofac Surg; 2012 Jul; 70(7):1573-83. PubMed ID: 22698292
[TBL] [Abstract][Full Text] [Related]
8. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices.
Fugazzotto PA; Lightfoot WS; Jaffin R; Kumar A
J Periodontol; 2007 Sep; 78(9):1664-9. PubMed ID: 17760533
[TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: report of 2 cases.
Lee JJ; Cheng SJ; Wang YP; Jeng JH; Chiang CP; Kok SH
Head Neck; 2013 Jan; 35(1):E6-10. PubMed ID: 21523843
[TBL] [Abstract][Full Text] [Related]
10. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
Abu-Id MH; Warnke PH; Gottschalk J; Springer I; Wiltfang J; Acil Y; Russo PA; Kreusch T
J Craniomaxillofac Surg; 2008 Mar; 36(2):95-103. PubMed ID: 18234504
[TBL] [Abstract][Full Text] [Related]
11. Osteonecrosis of the jaw onset times are based on the route of bisphosphonate therapy.
Fleisher KE; Jolly A; Venkata UD; Norman RG; Saxena D; Glickman RS
J Oral Maxillofac Surg; 2013 Mar; 71(3):513-9. PubMed ID: 22999296
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study.
Scoletta M; Arduino PG; Dalmasso P; Broccoletti R; Mozzati M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jul; 110(1):46-53. PubMed ID: 20452252
[TBL] [Abstract][Full Text] [Related]
13. Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate.
Ulmner M; Jarnbring F; Törring O
J Oral Maxillofac Surg; 2014 Jan; 72(1):76-82. PubMed ID: 23992777
[TBL] [Abstract][Full Text] [Related]
14. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
Kunchur R; Need A; Hughes T; Goss A
J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report.
Rugani P; Acham S; Truschnegg A; Obermayer-Pietsch B; Jakse N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):e1-6. PubMed ID: 21112522
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-associated osteonecrosis of the jaws -- report of three cases in Bulgaria and review of the literature.
Pechalova P; Bakardjiev A; Zaprianov Z; Vladimirov B; Poriazova E; Zheleva A; Hadjigeorgiev G; Goranova-Marinova V; Goranov S
Acta Clin Croat; 2011 Jun; 50(2):273-9. PubMed ID: 22263396
[TBL] [Abstract][Full Text] [Related]
17. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
Chiu CT; Chiang WF; Chuang CY; Chang SW
J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment.
Otto S; Schreyer C; Hafner S; Mast G; Ehrenfeld M; Stürzenbaum S; Pautke C
J Craniomaxillofac Surg; 2012 Jun; 40(4):303-9. PubMed ID: 21676622
[TBL] [Abstract][Full Text] [Related]
19. [Surgical treatment of maxillary osteonecrosis due to bisphosphonates using an Er:YAG (2940 nm) laser. Discussion of 17 clinical cases].
Vescovi P; Merigo E; Manfredi M; Meleti M; Fornaini C; Bonanini M; Rocca EP; De Moor RJ; Nammour S
Rev Belge Med Dent (1984); 2009; 64(2):87-95. PubMed ID: 19681350
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons.
Khan AA; Rios LP; Sándor GK; Khan N; Peters E; Rahman MO; Clokie CM; Dore E; Dubois S
J Rheumatol; 2011 Jul; 38(7):1396-402. PubMed ID: 21498483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
